Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Insulin Pump Market, by Product
1.4.2 Europe Insulin Pump Market, by Disease Indication
1.4.3 Europe Insulin Pump Market, by Distribution Channel
1.4.4 Europe Insulin Pump Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trials and Approvals
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Mar) Leading Players
Chapter 4. Europe Insulin Pump Market by Product
4.1 Europe Pumps Market by Country
4.2 Europe Insulin Pump Market by Pumps Type
4.2.1 Europe Tethered Market by Country
4.2.2 Europe Patch Market by Country
4.2.3 Europe Others Market by Country
4.3 Europe Consumables Market by Country
Chapter 5. Europe Insulin Pump Market by Disease Indication
5.1 Europe Type 1 Diabetes Market by Country
5.2 Europe Type 2 Diabetes Market by Country
Chapter 6. Europe Insulin Pump Market by Distribution Channel
6.1 Europe Retail & Online Pharmacies Market by Country
6.2 Europe Hospital Pharmacy Market by Country
Chapter 7. Europe Insulin Pump Market by Country
7.1 Germany Insulin Pump Market
7.1.1 Germany Insulin Pump Market by Product
7.1.1.1 Germany Insulin Pump Market by Pumps Type
7.1.2 Germany Insulin Pump Market by Disease Indication
7.1.3 Germany Insulin Pump Market by Distribution Channel
7.2 UK Insulin Pump Market
7.2.1 UK Insulin Pump Market by Product
7.2.1.1 UK Insulin Pump Market by Pumps Type
7.2.2 UK Insulin Pump Market by Disease Indication
7.2.3 UK Insulin Pump Market by Distribution Channel
7.3 France Insulin Pump Market
7.3.1 France Insulin Pump Market by Product
7.3.1.1 France Insulin Pump Market by Pumps Type
7.3.2 France Insulin Pump Market by Disease Indication
7.3.3 France Insulin Pump Market by Distribution Channel
7.4 Russia Insulin Pump Market
7.4.1 Russia Insulin Pump Market by Product
7.4.1.1 Russia Insulin Pump Market by Pumps Type
7.4.2 Russia Insulin Pump Market by Disease Indication
7.4.3 Russia Insulin Pump Market by Distribution Channel
7.5 Spain Insulin Pump Market
7.5.1 Spain Insulin Pump Market by Product
7.5.1.1 Spain Insulin Pump Market by Pumps Type
7.5.2 Spain Insulin Pump Market by Disease Indication
7.5.3 Spain Insulin Pump Market by Distribution Channel
7.6 Italy Insulin Pump Market
7.6.1 Italy Insulin Pump Market by Product
7.6.1.1 Italy Insulin Pump Market by Pumps Type
7.6.2 Italy Insulin Pump Market by Disease Indication
7.6.3 Italy Insulin Pump Market by Distribution Channel
7.7 Rest of Europe Insulin Pump Market
7.7.1 Rest of Europe Insulin Pump Market by Product
7.7.1.1 Rest of Europe Insulin Pump Market by Pumps Type
7.7.2 Rest of Europe Insulin Pump Market by Disease Indication
7.7.3 Rest of Europe Insulin Pump Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Tandem Diabetes Care, Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Trials and Approvals:
8.2 SOOIL Developments Co., Ltd
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.3 Jiangsu Delfu Medical Device Co.,Ltd
8.3.1 Company Overview
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Insulet Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Trials and Approvals:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Geographical Expansions:
8.7 Ypsomed AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.8 Aetna, Inc. (CVS Pharmacy, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.9 Diabeloop SA
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. APEX Medical Corporation
8.10.1 Company Overview
Unique Offerings 